200 years and counting: The surprising persistence of the stethoscope

Despite dramatic advances in healthcare and technology over the past two centuries, most doctors still rely on a 200-year-old device to evaluate their patients: the humble stethoscope.

But why?

“When someone comes into your office saying they’re short of breath, you’re not going to just send them to an MRI without at least doing a physical exam first,” wrote Kaleigh Rogers in an article recently published online by Motherboard. “But new technologies are starting to give the stethoscope a run for its money.”

Those developing technologies—including handheld ultrasound, which allows doctors to see inside a patient’s chest from the comfort of their office—have some disadvantages that the simplistic stethoscope does not, according to Rogers.

“First of all … these devices cost between $5,000 and $10,000 (compared to $200 or less for a stethoscope),” she wrote. “They also are not quite refined enough to catch everything a stethoscope might.”

But perhaps the biggest reason the stethoscope persists, not only as an important diagnostic tool but as an iconic symbol of the medical profession, is the connection it represents between doctors and patients.

“The physical closeness between doctor and patient that stethoscopes require is a rare commodity in a time when doctors are often overworked and rushed,” Roger wrote.

Check out the link below to read the full article:

John Hocter,

Digital Editor

With nearly a decade of experience in print and digital publishing, John serves as Content Marketing Manager. His professional skill set includes feature writing, content marketing and social media strategy. A graduate of The Ohio State University, John enjoys spending time with his wife and daughter, along with a number of surprisingly mischievous indoor cacti.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.